Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/23/2024

Janusmed amning

Janusmed amning – Lamotrigin Mylan

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Lamotrigin Testmiljö

Lamotrigin

Klass : 2

  1. Rambeck B, Kurlemann G, Stodieck SR, May TW, Jurgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51(6):481-484
  2. Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38(9):1039-1041
  3. Öhman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41(6):709-713
  4. Page-Sharp M, Kristensen JH, Hackett LP, Beran RG, Rampono J, Hale TW et al. Transfer of lamotrigine into breast milk. Ann Pharmacother 2006;40(7-8):1470-1471
  5. Liporace J, Kao A, DAbreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004;5(1):102-105
  6. Ivana K, Milan G, Blanka K, Hana B. Therapeutic monitoring of lamotrigine during delivery, in the neonatal period, and during lactation. Ther Drug Monit 2007;29(4):477
  7. Gentile S. Lamotrigine in pregnancy and lactation. Arch Womens Ment Health 2005;8(1):57-8.
  8. Pennell P, Ritchie J, Newport D, Liporace J, Montgomery J, Newman M et al. Pharmacokinetics of lamotrigine excretion into human breast milk. Neurology 2006;66(5;Suppl 2):A72-A73
  9. Berry DJ. The disposition of lamotrigine throughout pregnancy. Ther Drug Monit 1999;21(4):450
  10. Öhman I, Tomson T, Vitols S. Lamotrigine (LTG) pharmacokinetics during delivery and lactation. Ther Drug Monit 1999;21(4):478
  11. Popescu L, Marceanu M, Moleavin I. Withdrawal of lamotrigine caused by sudden weaning of a newborn: a case report. Epilepsia 2005;46(suppl 6):407
  12. Nordmo E, Aronsen L, Wasland K, Småbrekke L, Vorren S. Severe apnea in an infant exposed to lamotrigine in breast milk. Ann Pharmacother. 2009;43:1893-7.
  13. Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B et al. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics. 2008;122:e223-31.
  14. Anna Westrup, barnläkare Blekingesjukhuset (personlig kommunikation).
  15. Fotopoulou C, Kretz R, Bauer S, Schefold JC, Schmitz B, Dudenhausen JW et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res. 2009;85:60-4.
  16. Precourt A, Morin C. Use of lamotrigine during breastfeeding: descriptive analysis of our population and report of five cases of premature neonates Abstract. Breastfeed Med. 2011;6 (Suppl 1):S-18.
  17. Clark CT, Klein AM, Perel JM, Helsel J, Wisner KL. Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry. 2013;170:1240-7.
  18. Karcirova I, Grundmann M, Brozmanova H. Drug interaction between lamotrigine and valproic acid used at delivery and during lactation - a case report Abstract. Basic Clin Pharmacol Toxicol. 2011;109:134.
  19. Karcirova I, Grundmann M, Brozmanova H. Serum levels of lamotrigine in breastfeeding mothers, maternal milk and nursed infants Abstract. Basic Clin Pharmacol Toxicol. 2011;109:134.
  20. Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005;46(5):775-777
  21. Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168:729-36.
  22. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010;75:1954-60.
  23. Birnbaum AK, Meador KJ, Karanam A, Brown C, May RC, Gerard EE et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol. 2020;77(4):441-450.
  24. Paulzen M, Stingl JC, Augustin M, Saßmannshausen H, Franz C, Gründer G et al. Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine. Clin Pharmacokinet. 2019;58(4):535-543.
  25. Bedussi F, Relli V, Faraoni L, Eleftheriou G, Giampreti A, Gallo M et al. Normocytic Normochromic Anaemia and Asymptomatic Neutropenia in a 40-Day-Old Infant Breastfed by an Epileptic Mother Treated With Lamotrigine: Infant's Adverse Drug Reaction. J Paediatr Child Health. 2018;54(1):104-105.
  26. Kacirova I, Grundmann M, Brozmanova H. A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month . Ther Drug Monit . 2019;3(41):401-404 .
  27. Yashima K, Obara T, Matsuzaki F, Suzuki C, Saeki M, Koyama M et al. Evaluation of the Safety of Taking Lamotrigine During Lactation Period. Breastfeed Med. 2021;16(5):432-438.
  28. Kohn E, Dinavitser N, Berlin M, Brandriss N, Bar-Chaim A, Gueta I et al. Magnitude of Lamotrigine Exposure Through Breastfeeding. Breastfeed Med. 2022;17(4):341-348.
  29. Khosrowshahi EM, Jouyban A, Farajzadeh MA, Tuzen M, Afshar Mogaddam MR, Nemati M. pH-induced homogeneous liquid-liquid microextraction method based on new switchable deep eutectic solvent for the extraction of three antiepileptic drugs from breast milk. Bioanalysis. 2021;13(14):1087-1099.
  30. Kacirova I, Grundmann M, Brozmanova H. A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month . Ther Drug Monit . 2019;3(41):401-404 .

Innehållet senast uppdaterat 11/7/2024